Similar articles for PMID: 22098228

Year	Number of Results
1987	1
1996	1
1999	1
2000	4
2002	1
2003	3
2004	1
2005	4
2006	7
2007	8
2008	14
2009	14
2010	15
2011	23
2012	18
2013	20
2014	15
2015	9
2016	13
2017	13
2018	13
2019	4
2021	2
2022	1
2024	0

1

Treating chronic lymphocytic leukemia with thalidomide and lenalidomide.

Giannopoulos K, Mertens D, Stilgenbauer S. Giannopoulos K, et al. Expert Opin Pharmacother. 2011 Dec;12(18):2857-64. doi: 10.1517/14656566.2011.635644. Expert Opin Pharmacother. 2011. PMID: 22098228 Review.

2

Lenalidomide in the treatment of chronic lymphocytic leukemia.

Gentile M, Recchia AG, Vigna E, Mazzone C, Lucia E, Gigliotti V, Bossio S, Madeo A, Morabito L, Servillo P, Franzese S, Caruso N, De Stefano L, Bisconte MG, Gentile C, Morabito F. Gentile M, et al. Expert Opin Investig Drugs. 2011 Feb;20(2):273-86. doi: 10.1517/13543784.2011.546343. Epub 2011 Jan 10. Expert Opin Investig Drugs. 2011. PMID: 21214505 Review.

3

Lenalidomide in lymphomas and chronic lymphocytic leukemia.

Wiernik PH. Wiernik PH. Expert Opin Pharmacother. 2013 Mar;14(4):475-88. doi: 10.1517/14656566.2013.765858. Epub 2013 Jan 29. Expert Opin Pharmacother. 2013. PMID: 23356486 Review.

4

Lenalidomide in CLL: what is the optimal dose?

Wendtner CM. Wendtner CM. Clin Adv Hematol Oncol. 2011 Mar;9(3):220-4. Clin Adv Hematol Oncol. 2011. PMID: 21475128 No abstract available.

5

Lenalidomide in the treatment of chronic lymphocytic leukemia.

Itchaki G, Brown JR. Itchaki G, et al. Expert Opin Investig Drugs. 2017 May;26(5):633-650. doi: 10.1080/13543784.2017.1313230. Epub 2017 Apr 17. Expert Opin Investig Drugs. 2017. PMID: 28388253 Review.

6

The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).

Dawar R, Hernandez-Ilizaliturri F. Dawar R, et al. Best Pract Res Clin Haematol. 2012 Jun;25(2):185-90. doi: 10.1016/j.beha.2012.04.005. Epub 2012 May 18. Best Pract Res Clin Haematol. 2012. PMID: 22687454 Review.

7

Management of patients with chronic lymphocytic leukemia treated with lenalidomide.

Miller KC, Musial L, Whitworth A, Chanan-Khan A. Miller KC, et al. Clin J Oncol Nurs. 2010 Aug;14(4):491-9. doi: 10.1188/10.CJON.491-499. Clin J Oncol Nurs. 2010. PMID: 20682505 Review.

8

Lenalidomide alone and in combination for chronic lymphocytic leukemia.

Chen CI. Chen CI. Curr Hematol Malig Rep. 2013 Mar;8(1):7-13. doi: 10.1007/s11899-012-0146-x. Curr Hematol Malig Rep. 2013. PMID: 23254517 Review.

9

Lenalidomide and chronic lymphocytic leukemia.

González-Rodríguez AP, Payer AR, Acebes-Huerta A, Huergo-Zapico L, Villa-Alvarez M, Gonzalez-García E, Gonzalez S. González-Rodríguez AP, et al. Biomed Res Int. 2013;2013:932010. doi: 10.1155/2013/932010. Epub 2013 Sep 19. Biomed Res Int. 2013. PMID: 24163824 Free PMC article. Review.

10

Lenalidomide for the treatment of B-cell malignancies.

Chanan-Khan AA, Cheson BD. Chanan-Khan AA, et al. J Clin Oncol. 2008 Mar 20;26(9):1544-52. doi: 10.1200/JCO.2007.14.5367. Epub 2008 Feb 19. J Clin Oncol. 2008. PMID: 18285605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

181 results

Results by year